Showing results (1991-2000 of 6,773) with videos related to

Sort By:
Pageof 678
Clinical Therapeutics|August 24, 2021
Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) StudyLisa Chu, Mark Fuller, Kathyrn Jervis, et al.
Clinical Therapeutics|August 12, 2021
Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United StatesCynthia Z Qi, Vamsi Bollu, Hongbo Yang, et al.
Clinical Therapeutics|May 28, 2020
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652, a Reversible Fatty Acid Amide Hydrolase Inhibitor, in Healthy, Nonelderly, Japanese Men and Elderly, Japanese Men and Women: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Phase I StudyMasaomi Takizawa, Toshifumi Hatta, Hiromi Iitsuka, et al.
Clinical Therapeutics|September 6, 2021
Pooled Analysis of Gastric Emptying in Patients With Obesity: Implications for Oral Absorption ProjectionChen-Xi Lu, Xiao-Xiao An, Yichao Yu, et al.
Clinical Therapeutics|August 30, 2021
A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral VareniclineJeffrey Nau, David J Wyatt, Hans Rollema, et al.
Clinical Therapeutics|August 9, 2021
Two Sides of the Same Coin? A Dual Multiple Criteria Decision Analysis of Novel Treatments Against Rheumatoid Arthritis in Physicians and PatientsKostas Athanasakis, Michael Igoumenidis, Nadia Boubouchairopoulou, et al.
Clinical Therapeutics|August 8, 2022
Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems, and Processes of Large, Medium, and Small Companies: An Industry SurveyPaul Beninger, Patrick Caubel, Latika Sharma, et al.
Clinical Therapeutics|August 13, 2022
The Ultramarathon of Gene Therapy Development for Rare Diseases: How Can We Cross the Finish Line Together?Erin Ward
Clinical Therapeutics|August 14, 2022
Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized TrialGail L Torkildsen, Guruprasad R Pattar, Gary Jerkins, et al.
Clinical Therapeutics|August 14, 2022
Pediatric Off-label Antipsychotic Use for Attention-Deficit/Hyperactivity DisorderHaeyoung Lee, Chengchen Zhang, Roderick Rose, et al.
Pageof 678